CARD11 and mantle cell lymphoma: But notably, CARD11 mutations tended to be more frequent in relapse tumors, although not to a significant degree (36.4% (4/11) at relapse vs. 22.9% (43/188) in primary MCL, p = 0.2190, Table S7).